Is It Time to Raise the Threshold for Critically Low Fibrinogen? Insights From a Retrospective, Consecutive‐Case Cohort Study of Low Fibrinogen due to Various Causes

ABSTRACT Introduction Fibrinogen deficiency is an important coagulation abnormality, with diverse causes. Methods A consecutive‐case cohort study of adult and pediatric patients with low Clauss fibrinogen at four acute care hospitals was undertaken to explore findings, causes, and predictors of outcomes, including the optimal fibrinogen critical value to predict all‐cause mortality. Results Over 11 months, 4.9% of tested patients (349/7183, after excluding n = 4 for preanalytical errors) had fibrinogen deficiency (63.6% male; 86.8% adult; 29.2% with liver disease; 14.0% with massive transfusion; 19.5% with fibrinogen < 1.0 g/L, the historical critical value; none with a diagnosed inherited deficiency). Primary causes of fibrinogen deficiency were: cardiovascular surgery (CVS); trauma; overt, not overt and potential/not scorable (no D‐dimer results) disseminated intravascular coagulation (DIC); liver disease; acute bleeding; and other (including uncertain) causes. After Bonferroni correction, overt and potential/not scorable DIC were associated with significantly lower fibrinogen levels and higher mortality than most other causes were, particularly compared to trauma ( p < 0.0001). Median time to death after diagnosing fibrinogen deficiency was 1 (IQR: < 1–7) day. A Clauss fibrinogen ≤ 1.3 g/L had optimal sensitivity and specificity for predicting mortality among fibrinogen‐deficient patients, and multivariate analyses indicated it was a strong, independent predictor of death (adjusted odds ratio [95% confidence intervals]: 6.2 [2.9–13.6] vs. ≤ 3.6 for liver disease and DIC). Spearman correlation indicated that the nadir Clauss fibrinogen level had a negative correlation ( r = −0.34, p < 0.0001) to the amount of fibrinogen replacement received. Conclusions Low Clauss fibrinogen was commonly acquired and levels ≤ 1.3 g/L were optimal for predicting all‐cause mortality.

Authors

Institutions

Publication Details

Journal
International Journal of Laboratory Hematology
Published
2026-09-11
DOI
https://doi.org/10.1111/ijlh.70246
Primary Topic
Blood properties and coagulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Is It Time to Raise the Threshold for Critically Low Fibrinogen? Insights From a Retrospective, Consecutive‐Case Cohort Study of Low Fibrinogen due to Various Causes

Natalie Mathews, Catherine P.M. Hayward, Yasmeen Abulkhair, Siraj Mithoowani et al.
International Journal of Laboratory Hematology
Blood properties and coagulation
article

Is It Time to Raise the Threshold for Critically Low Fibrinogen? Insights From a Retrospective, Consecutive‐Case Cohort Study of Low Fibrinogen due to Various Causes

Natalie Mathews, Catherine P.M. Hayward, Yasmeen Abulkhair, Siraj Mithoowani, Keona Ka Ying Pang, Guillaume Paré, Subia Tasneem, Mana Al Dawsari
article en

Abstract

ABSTRACT Introduction Fibrinogen deficiency is an important coagulation abnormality, with diverse causes. Methods A consecutive‐case cohort study of adult and pediatric patients with low Clauss fibrinogen at four acute care hospitals was undertaken to explore findings, causes, and predictors of outcomes, including the optimal fibrinogen critical value to predict all‐cause mortality. Results Over 11 months, 4.9% of tested patients (349/7183, after excluding n = 4 for preanalytical errors) had fibrinogen deficiency (63.6% male; 86.8% adult; 29.2% with liver disease; 14.0% with massive transfusion; 19.5% with fibrinogen < 1.0 g/L, the historical critical value; none with a diagnosed inherited deficiency). Primary causes of fibrinogen deficiency were: cardiovascular surgery (CVS); trauma; overt, not overt and potential/not scorable (no D‐dimer results) disseminated intravascular coagulation (DIC); liver disease; acute bleeding; and other (including uncertain) causes. After Bonferroni correction, overt and potential/not scorable DIC were associated with significantly lower fibrinogen levels and higher mortality than most other causes were, particularly compared to trauma ( p < 0.0001). Median time to death after diagnosing fibrinogen deficiency was 1 (IQR: < 1–7) day. A Clauss fibrinogen ≤ 1.3 g/L had optimal sensitivity and specificity for predicting mortality among fibrinogen‐deficient patients, and multivariate analyses indicated it was a strong, independent predictor of death (adjusted odds ratio [95% confidence intervals]: 6.2 [2.9–13.6] vs. ≤ 3.6 for liver disease and DIC). Spearman correlation indicated that the nadir Clauss fibrinogen level had a negative correlation ( r = −0.34, p < 0.0001) to the amount of fibrinogen replacement received. Conclusions Low Clauss fibrinogen was commonly acquired and levels ≤ 1.3 g/L were optimal for predicting all‐cause mortality.

International Journal of Laboratory Hematology
Centre Hospitalier Universitaire Sainte-Justine (CA), Population Health Research Institute (CA), Hamilton Regional Laboratory Medicine Program (CA), Ministry of Health (SA), Ministry of Health (MM), Impact (CA), Université de Montréal (CA), McMaster University (CA)
Good health and well-being
Openalex Percentile: Top 11%
Blood properties and coagulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.